Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing

Ultrasound in Obstetrics and Gynecology

Volumn 36, Issue 5, 2010, Pages 542-547

  Kagan, K O ^a   Staboulidou, I ^b   Cruz, J ^c   Wright, D ^d   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

ductus venosus flow; nasal bone; nuchal translucency; screening for trisomy 21; tricuspid regurgitation

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD; CHEMISTRY; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; METHODOLOGY; MIDDLE AGED; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; HUMANS; MATERNAL AGE; MIDDLE AGED; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

EID: 78349280822     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7663     Document Type: Article

References (24)

1. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH,. Screening for trisomy 21 by maternal age fetal nuchal translucency thickness, free beta human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31: 618 - 624.
2. Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH,. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33: 259 - 264.
3. Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH,. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33: 512 - 517.
4. Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH,. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33: 18 - 22.
5. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH,. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343 - 346.
6. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O,. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221 - 226.
7. Cicero S, Dezerega V, Andrade E, Scheier M, Nicolaides KH,. Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks. Ultrasound Obstet Gynecol 2003; 22: 135 - 137.
8. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K,. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001; 358: 1665 - 1667.
9. Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH,. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006; 195: 109 - 114.
10. Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH,. Learning curve for Doppler assessment of ductus venosus flow at 11 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2008; 31: 503 - 506.
11. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH,. Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006; 27: 609 - 612.
12. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376 - 383.
13. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH,. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493 - 502.
14. Office for National Statistics. Birth Statistics. Review of the Registrar General on Births and Patterns of Family Building in England and Wales, 2000-2002. Series FM1, No. 29-31. Stationery Office: London.
15. Cuckle HS, Wald NJ, Thompson SG,. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387 - 402.
16. Bray IC, Wright DE,. Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth. Prenat Diagn 1998; 18: 1045 - 1054.
17. NSC, UK National Screening Committee. Antenatal Screening - Working Standards for Down's Syndrome Screening 2007. [Accessed 22 February 2010].
18. Sahota DS, Leung TY, Chan LW, Law LW, Fung TY, Chen M, Lau TK,. Comparison of first-trimester contingent screening strategies for Down syndrome. Ultrasound Obstet Gynecol 2010; 35: 286 - 291.
19. Vadiveloo T, Crossley JA, Aitken DA,. First-trimester contingent screening for Down syndrome can reduce the number of nuchal translucency measurements required. Prenat Diagn 2009; 29: 79 - 82.
20. Christiansen M, Olesen Larsen S,. An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing. Prenat Diagn 2002; 22: 482 - 486.
21. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K,. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 2004; 24: 762 - 766.
22. Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH,. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 + 6 weeks of gestation. Obstet Gynecol 2008; 112: 598 - 605.
23. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH,. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005; 26: 22 - 27.
24. Campbell S, Platt L,. The publishing of papers on first-trimester Doppler. Ultrasound Obstet Gynecol 1999; 14: 159 - 160.